Trade ICCC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
ImmuCell Corporation (ICCC) is trading at US$9.94, down 0.80% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$91.37M. Over the past 52 weeks, ICCC has traded between US$4.52 and US$12.10. On Syfe you can trade ICCC with $0 commission and add it to your watchlist.
| Previous close | US$10.02 |
|---|---|
| Market cap | US$91.37M |
| 52-week range | US$4.52 – US$12.10 |
| Volume | 5.61K |
| Exchange | US |
Add to Watchlist
Set Price Alert
ImmuCell Corporation
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. It operates through the following segments: Scours and Mastitis. The Scours segment consists of the First Defense product line. The Mastitis segment includes the CMT product line consisting of reagents and equipment used for rapid cow-side testing to identify mastitic quarters by detecting elevated somatic cell counts. The company was founded in 1982 and is headquartered in Portland, ME.
Year: 1987
ImmuCell Q1 Sales Jump; Shares Rise After Hours
Apr 8, 9:02 PM · MT Newswires
ImmuCell Corporation (ICCC) stock is trading at US$9.94, -0.80% from the previous close of US$10.02.
The market cap for ImmuCell Corporation (ICCC) stock is approximately US$91.37M.
The 52-week high for ImmuCell Corporation (ICCC) stock is US$12.10.
The 52-week low for ImmuCell Corporation (ICCC) stock is US$4.52.
ImmuCell Corporation (ICCC) does not currently pay a dividend.
Stay on top of ICCC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
